Andrea Zuckerman
Overview
Explore the profile of Andrea Zuckerman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pfeifer S, Attaran M, Goldstein J, Lindheim S, Petrozza J, Rackow B, et al.
Fertil Steril
. 2021 Nov;
116(5):1238-1252.
PMID: 34756327
There are many proposed classification systems for müllerian anomalies. The American Fertility Society (AFS) Classification from 1988 has been the most recognized and utilized. The advantages of this iconic classification...
2.
Lindheim S, Pfeifer S, Rackow B, Petrozza J, Attaran M, Zuckerman A, et al.
Fertil Steril
. 2021 Sep;
116(4):959-960.
PMID: 34579829
No abstract available.
3.
Zuckerman A, Romano M
J Pediatr Adolesc Gynecol
. 2016 Dec;
29(6):673-679.
PMID: 27969009
Vulvovaginitis is a commonly encountered condition among prepubertal and adolescent females. The objective of this report is to provide the latest evidence regarding the diagnosis and management of vulvovaginitis in...
4.
Charles-Schoeman C, Wicker P, Gonzalez-Gay M, Boy M, Zuckerman A, Soma K, et al.
Semin Arthritis Rheum
. 2016 Jul;
46(3):261-271.
PMID: 27443588
Objectives: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). The implications of treatment with tofacitinib on cardiovascular (CV) risk in RA are unknown. Therefore,...
5.
Charles-Schoeman C, Gonzalez-Gay M, Kaplan I, Boy M, Geier J, Luo Z, et al.
Semin Arthritis Rheum
. 2016 Apr;
46(1):71-80.
PMID: 27079757
Cardiovascular (CV) morbidity and mortality are increased in patients with active, untreated rheumatoid arthritis (RA), despite lower levels of total and low-density lipoprotein cholesterol reported in individuals with active RA...
6.
Kremer J, Kivitz A, Simon-Campos J, Nasonov E, Tony H, Lee S, et al.
Arthritis Res Ther
. 2015 Apr;
17:95.
PMID: 25889308
Introduction: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). During the clinical development programme, increases in mean serum creatinine (SCr) of approximately 0.07 mg/dL...
7.
Charles-Schoeman C, Fleischmann R, Davignon J, Schwartz H, Turner S, Beysen C, et al.
Arthritis Rheumatol
. 2014 Dec;
67(3):616-25.
PMID: 25470338
Objective: Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis (RA). Systemic inflammation is proposed to play a fundamental role in the altered lipid metabolism associated with...
8.
Isaacs J, Zuckerman A, Krishnaswami S, Nduaka C, Lan S, Hutmacher M, et al.
Arthritis Res Ther
. 2014 Jul;
16(4):R158.
PMID: 25063045
Introduction: Small increases in mean serum creatinine (SCr) were observed in studies of rheumatoid arthritis patients during tofacitinib treatment. These SCr changes were investigated and potential mechanisms explored. Methods: SCr...
9.
McInnes I, Kim H, Lee S, Mandel D, Song Y, Connell C, et al.
Ann Rheum Dis
. 2013 Mar;
73(1):124-31.
PMID: 23482473
Objectives: To evaluate the efficacy and safety of atorvastatin versus placebo in modifying lipids in patients with rheumatoid arthritis (RA) receiving the oral Janus kinase inhibitor, tofacitinib. Methods: A randomised,...
10.
Koren M, Davidson M, Wilson D, Fayyad R, Zuckerman A, Reed D
Am J Kidney Dis
. 2009 Feb;
53(5):741-50.
PMID: 19216014
Background: This post hoc analysis of the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) Study investigates the effect of focused atorvastatin therapy versus usual care on cardiovascular outcomes in...